P2Y12 a new platelet ADP receptor, target of clopidogrel

Biochemical and Biophysical Research Communications

Volumn 283, Issue 2, 2001, Pages 379-383

  Savi, P ^a   Labouret, C ^a   Delesque, N ^a   Guette, F ^a   Lupker, J ^a   Herbert, J M ^a  

^a SANOFI   (France)

Author keywords

ADP; Clopidogrel; P2Y12; Platelets; Purinergic

Indexed keywords

ADENOSINE DIPHOSPHATE; ADENYLATE CYCLASE; CLOPIDOGREL; PURINE P2 RECEPTOR; RECEPTOR SUBTYPE; THROMBOCYTE RECEPTOR;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; CELL CULTURE; CHO CELL; CONTROLLED STUDY; DRUG MECHANISM; DRUG RECEPTOR BINDING; GENETIC TRANSFECTION; NONHUMAN; PRIORITY JOURNAL;

EID: 0034805389     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1006/bbrc.2001.4816     Document Type: Article

References (23)

1. Clopidogrel, a novel antiplatelet and antithrombotic agent
2. Pharmacology of ticlopidine and clopidogrel
3. A randomized, blinded, trial of SR25990C versus aspirin in patients at risk of ischaemic events (CAPRIE)
4. 3H]-2-methylthio ADP to rat platelets - Effect of clopidogrel and ticlopidine
5. Clopidogrel inhibits the binding of ADP analogues to the receptor mediating inhibition of platelet adenylate cyclase
6. Identification and biological activity of the active metabolite of clopidogrel
7. Role of P2Y1 purinoceptor in ADP-induced platelet activation
8. Characterization of P2x1 purinoreceptors on rat platelets: Effect of clopidogrel
9. ADP is the cognate ligand for orphan G-protein coupled receptor SP1999
10. Identification of the platelet ADP receptor targeted by antithrombotic drugs
11. Rapid isolation of highly productive recombinant Chinese hamster ovary cell lines
12. Isolation of Chinese hamster cell mutants deficient in dihydrofolate reductase activity
13. Methods in binding studies
14. Estimation of hormone receptor affinity by competitive displacement of labeled ligand: Effect of concentration of receptor and of labeled ligand
15. Relationship between the inhibition constant (Ki) and the concentration of inhibitor which causes 50 per cent inhibition (IC50) of an enzymatic reaction
16. Ligand: A versatile computerized approach for characterization of ligand-binding systems
17. Extraction of cyclic AMP for the determination in the competitive protein binding assay
18. The attractions of proteins for small molecules and ions
19. 32P] diphosphate. An agonist and radioligand for the receptor that inhibits the accumulation of cyclic AMP in intact blood platelets
20. Aggregin: A platelet ADP receptor that mediates activation
21. Synthesis, biological activity, and molecular modeling of ribose-modified deoxyadenosine bisphosphate analogues as P2Y(1) receptor ligands
22. Evidence for the existence of two different ADP-binding sites on rat platelets